Suspending methotrexate for 2 weeks after COVID-19 vaccination
Hlavní autoři: | Coates, LC, Abhishek, A |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2022
|
Podobné jednotky
-
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Autor: Abhishek, A, a další
Vydáno: (2022) -
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Autor: Abhishek Abhishek, a další
Vydáno: (2022-05-01) -
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Autor: Abhishek, A, a další
Vydáno: (2023) -
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Autor: Abhishek, A, a další
Vydáno: (2023) -
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Autor: Abhishek, A, a další
Vydáno: (2022)